Medically supervised GLP-1 weight management in Delray Beach, Florida
South Florida’s medically supervised weight loss experts. Real results, personalized care. At Allenby Cosmetic Dermatology and BodySquad, our team offers a comprehensive Semaglutide weight management program combining dual GIP/GLP-1 therapy with personalized monitoring and lifestyle support — giving you the tools you need to achieve lasting, meaningful results. Serving Delray Beach, Boca Raton, and South Florida, your weight loss journey starts here. Schedule your consultation today.
About Semaglutide®:
Semaglutide is a prescription GLP-1 receptor agonist clinically proven to support weight loss and improve metabolic health — when combined with personalized diet and lifestyle guidance. At Allenby Cosmetic Dermatology and BodySquad, our medically supervised program takes a whole-body approach, ensuring you feel supported, informed, and empowered every step of the way.
How it works:
Semaglutide works by regulating appetite and satiety through central nervous system pathways while slowing gastric emptying — helping you naturally reduce caloric intake and achieve gradual, sustainable weight loss without feeling deprived.
Why Choose Semaglutide?
Clinically supported weight loss:
Demonstrated reduction in body weight when combined with diet and activity changes
Appetite regulation:
Reduces hunger and cravings to support calorie control
Medically supervised:
Individualized dosing, monitoring, and follow up under physician care
Integrated approach:
Paired with nutrition and behavior support for sustainable results
Predictable titration:
Gradual dose escalation improves tolerability and adherence
Improved metabolic markers:
Many patients see benefits in blood glucose control and other cardiometabolic measures
Request Information or Consultation
Request a Consultation
"(Required)" indicates required fields
What to Expect with Your Semaglutide Journey?
Your initial visit includes a comprehensive medical evaluation, review of current medications and medical history, measurement of baseline weight and labs as indicated, and a discussion of goals. We determine candidacy and create a personalized plan including dosing schedule, monitoring frequency, and lifestyle supports.
Semaglutide is typically administered as a once weekly subcutaneous injection with a slow titration schedule to target dose. Office visits or telehealth follow ups monitor weight, symptoms, and any necessary labs or medication adjustments.
- Initiation and Titration: gradual dose increases over several weeks to improve tolerance
- Initial Weight Changes: many patients notice appetite reduction within 2 to 4 weeks and measurable weight loss within the first 1 to 3 months
- Typical Clinical Course: meaningful weight loss commonly accumulates over 3 to 6 months with continued improvement over time
- Maintenance: ongoing therapy and lifestyle support may be recommended to sustain results
There is no procedural downtime. Occasional gastrointestinal side effects such as nausea or constipation may occur and usually ease with dose adjustments and supportive measures.
Semaglutide is a prescription medication that requires medical evaluation and monitoring for side effects and interactions. It is not appropriate for pregnant individuals and should be avoided in patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2; we review contraindications and safety protocols during consultation.
Commonly Asked Questions
Explore Treatments
Botox®
The Gold Standard in Wrinkle Relaxation
Injectable Fillers
Restore volume and sculpt with natural precision and artistry.
CoolSculpting Elite
FDA-cleared non-invasive body contouring with lasting, natural results.
Laser Skin Rejuvenation
Reveal smoother, more radiant skin with advanced laser technology.
